Aquestive Therapeutics (NASDAQ:AQST – Get Rating) is scheduled to issue its quarterly earnings data after the market closes on Tuesday, May 2nd. Analysts expect the company to announce earnings of ($0.15) per share for the quarter. Aquestive Therapeutics has set its FY 2023 guidance at EPS.Parties that are interested in registering for the company’s conference […]
Aquestive Therapeutics, Inc. (NASDAQ:AQST – Get Rating) – Research analysts at Oppenheimer upped their Q1 2023 EPS estimates for shares of Aquestive Therapeutics in a note issued to investors on Thursday, March 9th. Oppenheimer analyst F. Brisebois now forecasts that the company will post earnings of $0.05 per share for the quarter, up from their […]
WARREN, N.J., Nov. 09, 2022 (GLOBE NEWSWIRE) Aquestive Therapeutics, Inc. (NASDAQ: AQST), a pharmaceutical company advancing current standards of care.